13
66
Growth Score 13 in past quarter
-9 pts
Heat Score 66 in past quarter
-1 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
660771
Persea is a biotechnology research company that developing a game-changing treatment against liver cancers called BioTrojan.
About the Company
Persea is a biotechnology research company that developing a game-changing treatment against liver cancers called BioTrojan.
Persea is a French biotechnology start-up that innovates Advanced Therapy Medical Products (ATMP) composed of allogeneic mesenchymal stem cells.
Their treatment is called BioTrojan in reference to the Trojan horse: it is
in short a cellular Trojan horse carrying a suicide gene which, once introduced into the tumor, reacts on contact with the cyclophosphamide acting as the messenger.
Founded in 2021 and is located in Paris, France.